Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05906745 · ClinicalTrials.gov registry record

Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.

A clinical trial of Heart Failure, sponsored by Tricog Health.

Completed
Registry status
52
Enrollment target
4
Study locations

NCT05906745: Completed study of Heart Failure, sponsored by Tricog Health.

NCT05906745 is a study of Heart Failure that has completed, run by Tricog Health. The registered enrollment target is 52 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05906745, a study of Heart Failure, has completed, sponsored by Tricog Health.

COMPLETED
Registry status
52 participants
Enrollment target
4
Study locations

Study Summary

A multicenter, non-randomized prospective longitudinal study to evaluate the feasibility of Tricog's Remote platform for Guideline Directed Medical Therapy (GDMT) titration and remote patient monitoring among patients with Heart Failure.

Primary Outcome

Serum level of N-terminal pro B-type natriuretic peptide

Conditions Studied

Heart Failure

Study Locations (4)

Karnataka

  • Manipal Hospital - Bengaluru
  • Sakra World Hospital - Bengaluru

North Carolina

  • Duke University Medical Center - Durham

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2023-07-21
Est. Completion 2024-09-27
Tricog Health

1 total trials

What the finished NCT05906745 record still lists

NCT05906745 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT05906745 reports a single indexed study location in Karnataka, North Carolina, Texas.

Frequently Asked Questions

What is clinical trial NCT05906745 about?

NCT05906745 is a clinical study titled "Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.". A multicenter, non-randomized prospective longitudinal study to evaluate the feasibility of Tricog's Remote platform for Guideline Directed Medical Therapy (GDMT) titration and remote patient monitoring among patients with Heart Failure.

What is the current status of trial NCT05906745?

This trial is currently completed. The enrollment target is 52 participants. The study started on 2023-07-21. Estimated completion is 2024-09-27.

What conditions does trial NCT05906745 study?

This clinical trial studies the following conditions: Heart Failure.

Who is sponsoring clinical trial NCT05906745?

This trial is sponsored by Tricog Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05906745 being conducted?

This trial has 4 study locations across North Carolina, Texas, Karnataka. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05906745's enrollment target sits among peer trials

52 280th of 397 higher than 118 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02630121 · 52 participants · Phase 4

    Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

  • NCT03629171 · 52 participants · Phase 2

    Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

  • NCT04128748 · 52 participants · Phase 1

    Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

  • NCT04150497 · 52 participants · Phase 1

    Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05906745, the US trial registry maintained by the National Library of Medicine. NCT05906745 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.